Recent research has unveiled a fascinating connection between mothers and their children, indicating that cells containing maternal DNA can persist in a child's brain for decades. This finding emphasizes the concept of "microchimerism," where maternal and fetal cells interchange during pregnancy, and adds a compelling layer to our understanding of biological relationships between mothers and their offspring.
Published in the preprint database bioRxiv, this study has not undergone peer review but contributes to a growing body of evidence that suggests such cellular exchanges are common and may play significant roles in health and development. While prior studies have identified maternal cells within the mothers' own brains, this research highlights the reverse phenomenon.
Amy Boddy, co-director of the Microchimerism, Human Health and Evolution Project at the University of California, Santa Barbara, not involved in the study, expressed excitement over the findings. Unlike earlier investigations that primarily detected maternal microchimerism in blood samples and infants, this research discovered maternal cells within brain tissues, presenting a major advancement in the field.
Identifying Maternal Cells in Brain Tissue
The challenge of capturing human brain tissue samples has historically hampered research in this area. However, researchers led by Sami Kanaan at the Fred Hutchinson Cancer Center in Seattle overcame this limitation by analyzing brain tissue removed from several children with severe epilepsy during their surgical treatments. Ranging from 28 days to 19 years old, these children provided a wealth of data through DNA samples obtained via cheek swabs from their mothers.
Using quantitative PCR, the team identified maternal DNA among millions of cells found in the children's brain samples. Out of 37 mother-child pairs analyzed, 70% exhibited maternal cells, distributed widely in various brain regions, including the frontal, temporal, and parietal lobes, as well as the hippocampus. Each brain sample revealed an average of about 2.2 maternal cells per 100,000, with some samples exhibiting numbers as high as 459 per 100,000, indicating a potentially broader presence of maternal cells than previously established.
An intriguing trend emerged: firstborn children were more likely to harbor maternal cells compared to their siblings. Among the children with maternal microchimeric cells, 14 were firstborns, while in the group lacking these cells, only one was a firstborn, hinting at a possible link between birth order and cellular retention.
Further investigation utilizing single nucleus RNA sequencing revealed that these maternal cells underwent transformation into several types of functional brain cells. Likely originating as leukocytes and stem cells, these cells may have been transferred through the placenta during pregnancy or through breastfeeding. The transformed cells included various types such as neurons, oligodendrocytes, astrocytes, microglia, and endothelial cells, which are integral to brain function.
Boddy remarked on the significance of utilizing advanced techniques like single-nucleus RNA sequencing, allowing researchers to gain insights into the functions of maternal microchimeric cells, a topic previously shrouded in mystery.
Extending the Research to Healthy Brains
Researchers sought to determine if these findings also applied to individuals without epilepsy by analyzing brain autopsy data from 29 brain samples, ranging from 22 weeks of gestation to 40 years old. Alongside this cohort, they examined brain tissues from three elderly men in their late 80s and early 90s, originally collected during Alzheimer's disease studies.
The results were striking: foreign cells were detected in 25 of these 32 individuals, equating to about 78%. While the research team suspects these foreign cells are of maternal origin, the lack of DNA from mothers prevents confirmation of this hypothesis. It’s important to consider alternative origins for these cells, such as from siblings, previous pregnancies, or even maternal grandmothers.
In alignment with findings from the epilepsy cohort, the foreign cells had developed into various functioning brain cells. Interestingly, younger brains tended to demonstrate a higher prevalence of layer 2/3 neurons, while in older brains, microglia appeared more frequently among the maternal cells, possibly reflecting their developmental trajectory and role in brain health.
The persistence of maternal microchimeric cells declines with age but doesn't entirely vanish, indicating that these cells may serve some ongoing function throughout life. "What roles could they play as we age?" Boddy pondered, suggesting that understanding their function could be key to grasping healthy brain development.
Kanaan’s research clears a path for further investigations. While this study represents a significant leap in understanding maternal microchimerism, a future focus on larger, more homogenous datasets would be beneficial. Collecting more brain biopsies, analyzing additional cells from each sample, and examining similar brain regions in various individuals could enhance the robustness of future studies.
The implications of these findings stretch beyond the confines of the study. They prompt new questions about the role of microchimeric cells in overall brain health and development. Understanding the functionality of these cells could lead to valuable insights in neuroscience, potentially reshaping our knowledge of brain biology.
